May 01, 2024 01:11 pm | Updated May 02, 2024 02:49 am IST - NEW DELHI:The controversy over the safety aspects of the Covishield vaccine reached the Supreme Court on Wednesday, May 1, 2024, with a petition seeking the constitution of an expert medical panel to study the risk factors. Also read: AstraZeneca’s submission in U.K. court nothing new, say doctors over Covishield’s potential to cause blood clots“More than 175 crore doses of Covishield have been administered in India. After Covid 19 there have been an increase in deaths due to heart attack and sudden collapse of persons. AIIMS expert-headed panel soughtThe petition said the medical.panel should be headed by an expert from AIIMS and supervised by a retired Supreme Court judge. The plea has also called for trict action against the circulation of spurious vaccines.

Source: The Hindu May 01, 2024 21:54 UTC